Delivery Order SPE2DB22D2009-SPE2DB25FM0ZP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count packaging) with a ceiling value of $1,573.01. This firm fixed-price delivery order is scheduled for ultimate completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation applied. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count packages) with a ceiling value of $1,150.23. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance of this contract is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $1,641.44. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Mucus Relief ER 600 mg tablets (500-count bottles) with a ceiling value of $1,195.33 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,106.16 to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets in a quantity of 500 units, with a contract ceiling value of $1,206.30. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,318.09 by the Defense Logistics Agency on August 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count containers). The contract is characterized as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and was awarded on a competitive basis without set-aside designation. Performance will occur at...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, valued at $2,271.04, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $2,680.12 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's headquarters location in Conshohocken,...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0ZPDelivery Order
The Defense Logistics Agency awarded a $4,812.83 delivery order to AmerisourceBergen Drug Corp for Mucus Relief DM ER 600-30 mg tablets (40 count) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract utilizing the company's existing indefinite delivery vehicle. The pharmaceutical supplies will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The DLA Troop Support Medical utilizes this flexible contracting mechanism to efficiently fulfill pharmaceutical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with AmerisourceBergen's track record demonstrating capability to meet federal procurement requirements through open competition across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/19/25 |